AI Summary
✦ ClarthaValuation Metrics
Trading 10.4% above historical median. Valuation is declining — currently in the fair zone (z-score: +0.45). Confidence: 85%.
Live forward EPS implies next-12-month EPS of ₹38.10. Applying the stock's normalized valuation corridor produces a fair range of ₹21,643.09 to ₹25,423.75, with base value near ₹22,985.35 (+4662.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹38.10
Forward P/E
12.7x
Base Fair Value
₹22,985.35
Fair Range
₹21,643.09 - ₹25,423.75
Upside To Base
+4662.8%
Estimate Source
Live forward EPS
5Y Average
469.90
Current
666.08
Overvalued
667.29
Undervalued
568.06
5Y Average
0.97
Current
1.11
Overvalued
1.12
Undervalued
0.82
5Y Average
0.74
Current
0.72
Overvalued
0.85
Undervalued
0.63
Peers & Comparison
Sector: Commodities
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
ALCODIS ALCODISChemicals | — | — | — | — | — |
ANYA ANYAChemicals | — | — | — | — | — |
BIOPOL BIOPOLChemicals | — | — | — | — | — |
PROLIFE.NS,0P00019KBP,1000 PROLIFEChemicals | — | — | 18.4x Undervalued | -24% vs avg | — |
RCDL.NS,0P0001RQEL,36000 RCDLChemicals | — | — | 6.7x Undervalued | -72% vs avg | — |
CONTI.NS,0P0001D340,23331 CONTIChemicals | — | — | 25.8x Fair | +7% vs avg | — |
SRF LTD SRFChemicals | +31.8% | 12.7% | 35.8x Premium | +48% vs avg | -9.2% |
AARTI INDUSTRIES LTD AARTIINDChemicals | +42.5% | 5.9% | 34.3x Premium | +42% vs avg | +33.9% |
Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹618 CrJun 2026Latest net profit
₹71 CrJun 2026Latest EPS
₹23.05Jun 2026Net margin
18.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 555 | 502 | 488 | 554 | 585 | 583 | 558 | 480 | 470 | 465 | 465 | 524 | 618 |
| Expenses + | 496 | 476 | 494 | 528 | 523 | 519 | 512 | 431 | 468 | 444 | 456 | 455 | 505 |
| Operating Profit | 59 | 26 | -6 | 26 | 62 | 64 | 46 | 49 | 2 | 21 | 10 | 69 | 113 |
| OPM % | 11% | 5% | -1.2% | 4.7% | 11% | 11% | 8% | 10% | 0.5% | 4.5% | 2.1% | 13% | 18% |
| Other Income + | 7 | 7 | 7 | 9 | 10 | 5 | 9 | 5 | 11 | 6 | 6 | 6 | 7 |
| Interest | 6 | 7 | 8 | 9 | 9 | 16 | 3 | 11 | 8 | 10 | 9 | 10 | 10 |
| Depreciation | 12 | 13 | 12 | 15 | 16 | 16 | 16 | 16 | 16 | 15 | 16 | 15 | 16 |
| Profit before tax | 48 | 14 | -20 | 11 | 46 | 36 | 35 | 27 | -11 | 2 | -9 | 49 | 95 |
| Tax % | 26% | 28% | -24% | 19% | 23% | 22% | 22% | 22% | -24% | 29% | -22% | 25% | 25% |
| Net Profit + | 36 | 10 | -15 | 9 | 35 | 28 | 28 | 21 | -8 | 1 | -7 | 37 | 71 |
| EPS in Rs | 11.58 | 3.27 | -4.95 | 2.99 | 11.51 | 9.19 | 9.01 | 6.81 | -2.67 | 0.46 | -2.34 | 12.07 | 23.05 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome